Thus, this study establishes a solid foundation for future investigations into the involvement of purinergic receptor deregulation in ASD, and the development of therapeutic strategies for treatment of this neurodevelopmental disorder. This evidence concerns the gene P2RX2 and neurodevelopmental disorder.